Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus

Sathyaprasad Burjonrappa, S. Reddimasu, Z. Nawaz, X. Gao, P. Sharma, B. Loggie

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

BACKGROUND: The molecular events that accompany the progression to adenocarcinoma (ADC) of the esophagus are poorly understood. Aberrant mucin receptor expression can contribute to increased cell growth and metastatic ability. AIM: The aim of this study was to establish a pattern for mucin (MUC) gene expression in the esophageal mucosa under normal and pathological conditions. SETTING: University Hospital Cancer Center Laboratory. Archived tissue samples studied in a retrospective fashion. MATERIALS AND METHODS: Tissue samples were obtained from the archives of patients with histological evidence of Barrett's esophagus (BE) progressing to ADC. Immunohistochemical analysis was performed using mouse monoclonal antibodies for MUC1, MUC2, MUC5AC, MUC6. Semiquantitative scoring of histological staining was performed using a linear scoring system: 0-staining absent; 1-staining in 0-25%; 2-staining in 25-50%; and 3-staining in 50-75% of the epithelium. The Binomial test was used to explore trends and differences in frequency of mucin expression along the pathological sequence. RESULTS: Only mild superficial staining of MUC1 was seen in normal squamous epithelium. MUC1 and MUC2 were uniformly expressed in all samples (7/7) of BE and dysplasia (P=0.008). MUC1 expression was upregulated (7/7) in progression to adenocarcinoma (P=0.008). The secretory mucins, MUC5AC and MUC6 showed a decrease in expression with progression from BE to dysplasia to ADC (P

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalIndian Journal of Cancer
Volume44
Issue number1
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Mucins
Esophagus
Adenocarcinoma
Staining and Labeling
Barrett Esophagus
Epithelium
Monoclonal Antibodies
Gene Expression
Growth
Neoplasms

Keywords

  • Barrett's esophagus
  • Mucin expression

ASJC Scopus subject areas

  • Medicine(all)
  • Cancer Research
  • Oncology

Cite this

Burjonrappa, S., Reddimasu, S., Nawaz, Z., Gao, X., Sharma, P., & Loggie, B. (2007). Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. Indian Journal of Cancer, 44(1), 1-5.

Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. / Burjonrappa, Sathyaprasad; Reddimasu, S.; Nawaz, Z.; Gao, X.; Sharma, P.; Loggie, B.

In: Indian Journal of Cancer, Vol. 44, No. 1, 01.01.2007, p. 1-5.

Research output: Contribution to journalArticle

Burjonrappa, S, Reddimasu, S, Nawaz, Z, Gao, X, Sharma, P & Loggie, B 2007, 'Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus', Indian Journal of Cancer, vol. 44, no. 1, pp. 1-5.
Burjonrappa, Sathyaprasad ; Reddimasu, S. ; Nawaz, Z. ; Gao, X. ; Sharma, P. ; Loggie, B. / Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. In: Indian Journal of Cancer. 2007 ; Vol. 44, No. 1. pp. 1-5.
@article{89cb0d4c13a04ce1b9a6f9136b03d509,
title = "Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus",
abstract = "BACKGROUND: The molecular events that accompany the progression to adenocarcinoma (ADC) of the esophagus are poorly understood. Aberrant mucin receptor expression can contribute to increased cell growth and metastatic ability. AIM: The aim of this study was to establish a pattern for mucin (MUC) gene expression in the esophageal mucosa under normal and pathological conditions. SETTING: University Hospital Cancer Center Laboratory. Archived tissue samples studied in a retrospective fashion. MATERIALS AND METHODS: Tissue samples were obtained from the archives of patients with histological evidence of Barrett's esophagus (BE) progressing to ADC. Immunohistochemical analysis was performed using mouse monoclonal antibodies for MUC1, MUC2, MUC5AC, MUC6. Semiquantitative scoring of histological staining was performed using a linear scoring system: 0-staining absent; 1-staining in 0-25{\%}; 2-staining in 25-50{\%}; and 3-staining in 50-75{\%} of the epithelium. The Binomial test was used to explore trends and differences in frequency of mucin expression along the pathological sequence. RESULTS: Only mild superficial staining of MUC1 was seen in normal squamous epithelium. MUC1 and MUC2 were uniformly expressed in all samples (7/7) of BE and dysplasia (P=0.008). MUC1 expression was upregulated (7/7) in progression to adenocarcinoma (P=0.008). The secretory mucins, MUC5AC and MUC6 showed a decrease in expression with progression from BE to dysplasia to ADC (P",
keywords = "Barrett's esophagus, Mucin expression",
author = "Sathyaprasad Burjonrappa and S. Reddimasu and Z. Nawaz and X. Gao and P. Sharma and B. Loggie",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
volume = "44",
pages = "1--5",
journal = "Indian Journal of Cancer",
issn = "0019-509X",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

TY - JOUR

T1 - Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus

AU - Burjonrappa, Sathyaprasad

AU - Reddimasu, S.

AU - Nawaz, Z.

AU - Gao, X.

AU - Sharma, P.

AU - Loggie, B.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - BACKGROUND: The molecular events that accompany the progression to adenocarcinoma (ADC) of the esophagus are poorly understood. Aberrant mucin receptor expression can contribute to increased cell growth and metastatic ability. AIM: The aim of this study was to establish a pattern for mucin (MUC) gene expression in the esophageal mucosa under normal and pathological conditions. SETTING: University Hospital Cancer Center Laboratory. Archived tissue samples studied in a retrospective fashion. MATERIALS AND METHODS: Tissue samples were obtained from the archives of patients with histological evidence of Barrett's esophagus (BE) progressing to ADC. Immunohistochemical analysis was performed using mouse monoclonal antibodies for MUC1, MUC2, MUC5AC, MUC6. Semiquantitative scoring of histological staining was performed using a linear scoring system: 0-staining absent; 1-staining in 0-25%; 2-staining in 25-50%; and 3-staining in 50-75% of the epithelium. The Binomial test was used to explore trends and differences in frequency of mucin expression along the pathological sequence. RESULTS: Only mild superficial staining of MUC1 was seen in normal squamous epithelium. MUC1 and MUC2 were uniformly expressed in all samples (7/7) of BE and dysplasia (P=0.008). MUC1 expression was upregulated (7/7) in progression to adenocarcinoma (P=0.008). The secretory mucins, MUC5AC and MUC6 showed a decrease in expression with progression from BE to dysplasia to ADC (P

AB - BACKGROUND: The molecular events that accompany the progression to adenocarcinoma (ADC) of the esophagus are poorly understood. Aberrant mucin receptor expression can contribute to increased cell growth and metastatic ability. AIM: The aim of this study was to establish a pattern for mucin (MUC) gene expression in the esophageal mucosa under normal and pathological conditions. SETTING: University Hospital Cancer Center Laboratory. Archived tissue samples studied in a retrospective fashion. MATERIALS AND METHODS: Tissue samples were obtained from the archives of patients with histological evidence of Barrett's esophagus (BE) progressing to ADC. Immunohistochemical analysis was performed using mouse monoclonal antibodies for MUC1, MUC2, MUC5AC, MUC6. Semiquantitative scoring of histological staining was performed using a linear scoring system: 0-staining absent; 1-staining in 0-25%; 2-staining in 25-50%; and 3-staining in 50-75% of the epithelium. The Binomial test was used to explore trends and differences in frequency of mucin expression along the pathological sequence. RESULTS: Only mild superficial staining of MUC1 was seen in normal squamous epithelium. MUC1 and MUC2 were uniformly expressed in all samples (7/7) of BE and dysplasia (P=0.008). MUC1 expression was upregulated (7/7) in progression to adenocarcinoma (P=0.008). The secretory mucins, MUC5AC and MUC6 showed a decrease in expression with progression from BE to dysplasia to ADC (P

KW - Barrett's esophagus

KW - Mucin expression

UR - http://www.scopus.com/inward/record.url?scp=34047122010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047122010&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 1

EP - 5

JO - Indian Journal of Cancer

JF - Indian Journal of Cancer

SN - 0019-509X

IS - 1

ER -